Literature DB >> 25598844

The role of radiotherapy-resistant stem cells in breast cancer recurrence.

Cheikh Menaa1, Jian Jian Li1.   

Abstract

Entities:  

Year:  2013        PMID： 25598844      PMCID： PMC4295787          DOI： 10.2217/bmt.13.5

Source DB:  PubMed          Journal:  Breast Cancer Manag        ISSN： 1758-1923


× No keyword cloud information.
  32 in total

Review 1.  Breast cancer stem cells, cytokine networks, and the tumor microenvironment.

Authors:  Hasan Korkaya; Suling Liu; Max S Wicha
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

2.  Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features.

Authors:  Chad J Creighton; Xiaoxian Li; Melissa Landis; J Michael Dixon; Veronique M Neumeister; Ashley Sjolund; David L Rimm; Helen Wong; Angel Rodriguez; Jason I Herschkowitz; Cheng Fan; Xiaomei Zhang; Xiaping He; Anne Pavlick; M Carolina Gutierrez; Lorna Renshaw; Alexey A Larionov; Dana Faratian; Susan G Hilsenbeck; Charles M Perou; Michael T Lewis; Jeffrey M Rosen; Jenny C Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-03       Impact factor: 11.205

3.  Lin28 regulates HER2 and promotes malignancy through multiple mechanisms.

Authors:  Chen Feng; Veronique Neumeister; Wei Ma; Jie Xu; Lingeng Lu; Jennifer Bordeaux; Nita J Maihle; David L Rimm; Yingqun Huang
Journal:  Cell Cycle       Date:  2012-07-01       Impact factor: 4.534

Review 4.  Radioresistance in carcinoma of the breast.

Authors:  J K A Jameel; V S R Rao; L Cawkwell; P J Drew
Journal:  Breast       Date:  2004-12       Impact factor: 4.380

5.  Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Authors:  Martine J Piccart-Gebhart; Marion Procter; Brian Leyland-Jones; Aron Goldhirsch; Michael Untch; Ian Smith; Luca Gianni; Jose Baselga; Richard Bell; Christian Jackisch; David Cameron; Mitch Dowsett; Carlos H Barrios; Günther Steger; Chiun-Shen Huang; Michael Andersson; Moshe Inbar; Mikhail Lichinitser; István Láng; Ulrike Nitz; Hiroji Iwata; Christoph Thomssen; Caroline Lohrisch; Thomas M Suter; Josef Rüschoff; Tamás Suto; Victoria Greatorex; Carol Ward; Carolyn Straehle; Eleanor McFadden; M Stella Dolci; Richard D Gelber
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

Review 6.  Overview of resistance to systemic therapy in patients with breast cancer.

Authors:  Ana Maria Gonzalez-Angulo; Flavia Morales-Vasquez; Gabriel N Hortobagyi
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

7.  Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials.

Authors: 
Journal:  N Engl J Med       Date:  1995-11-30       Impact factor: 91.245

Review 8.  Strategies to target HER2/neu overexpression for cancer therapy.

Authors:  Jin-Shing Chen; Kengli Lan; Mien-Chie Hung
Journal:  Drug Resist Updat       Date:  2003-06       Impact factor: 18.500

9.  Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab.

Authors:  Alessandra Magnifico; Luisa Albano; Stefano Campaner; Domenico Delia; Fabio Castiglioni; Patrizia Gasparini; Gabriella Sozzi; Enrico Fontanella; Sylvie Menard; Elda Tagliabue
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

10.  Lin28 and HER2: two stem cell regulators conspire to drive aggressive breast cancer.

Authors:  Fayaz Malik; Hasan Korkaya; Shawn G Clouthier; Max S Wicha
Journal:  Cell Cycle       Date:  2012-08-01       Impact factor: 4.534
View more
  5 in total

1.  Rac1 is a potential target to circumvent radioresistance.

Authors:  Wen-Ling Wang; Wei-Chien Huang
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

Review 2.  Cancer stem cell characteristics and their potential as therapeutic targets.

Authors:  Jacqueline R Lim; Josette Mouawad; Olivia K Gorton; William A Bubb; Ann H Kwan
Journal:  Med Oncol       Date:  2021-05-29       Impact factor: 3.064

3.  CPT1A/2-Mediated FAO Enhancement-A Metabolic Target in Radioresistant Breast Cancer.

Authors:  Shujun Han; Ryan Wei; Xiaodi Zhang; Nian Jiang; Ming Fan; Jie Hunter Huang; Bowen Xie; Lu Zhang; Weili Miao; Ashley Chen-Ping Butler; Matthew A Coleman; Andrew T Vaughan; Yinsheng Wang; Hong-Wu Chen; Jiankang Liu; Jian Jian Li
Journal:  Front Oncol       Date:  2019-11-15       Impact factor: 6.244

4.  Enhanced radiation response in radioresistant MCF-7 cells by targeting peroxiredoxin II.

Authors:  Anthony Joseph Gomez Diaz; Daniel Tamae; Yun Yen; Jianjian Li; Tieli Wang
Journal:  Breast Cancer (Dove Med Press)       Date:  2013-10-11

Review 5.  The role of peroxiredoxin II in chemoresistance of breast cancer cells.

Authors:  Tieli Wang; Anthony Joseph Gomez Diaz; Yun Yen
Journal:  Breast Cancer (Dove Med Press)       Date:  2014-05-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.